MOHAMMED AHMED: Open Payments
NPI 1184856916 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,229 in 48 payments from 11 companies in 2025. Trend: 2023 $10,561 · 2024 $3,358 · 2025 $1,229
Food & beverage: $1,229
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 9 | $210 |
| Axsome Therapeutics, Inc. | 6 | $149 |
| Janssen Pharmaceuticals, Inc | 5 | $144 |
| Neurocrine BioSciences, Inc. | 6 | $143 |
| ABBVIE INC. | 6 | $125 |
| PFIZER INC. | 1 | $116 |
| Eisai Inc. | 5 | $111 |
| Otsuka America Pharmaceutical, Inc. | 4 | $107 |
| Lilly USA, LLC | 3 | $61 |
| Biogen, Inc. | 2 | $45 |
Products named: REXULTI, LEQEMBI, Auvelity, SPRAVATO, INGREZZA, UBRELVY, NURTEC ODT, VYEPTI.
Industry payments across CA — which companies pay providers there.
